Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Singapore’s Pharma Market to Exceed $1B by 2019

By GlobalData | June 20, 2017

Singapore’s pharmaceutical market set to break $1 billion mark by 2019, says GlobalData.

The pharmaceutical market in Singapore is set to rise from $948 million in 2017 to around $1.2 billion in 2021, and will first exceed the $1 billion mark in 2019, according to research and consulting firm GlobalData.

The company’s latest report states that the market, which will expand at a compound annual growth rate of 5% during the forecast period, will be driven by universal access to health insurance and world-class biomedical research facilities.

With a population of only 5.6 million as of 2016, Singapore provides limited scope for domestic businesses to generate revenue. However, the country is a regional hub, and provides world-class infrastructure for manufacturing and R&D facilities of multinational pharmaceutical companies.

Singapore offers excellent opportunities for biomedical science companies thanks to its pro-business environment, low labor costs and corporate tax rate, and strong government support. Indeed, the government has spent billions of dollars attracting investment from foreign pharmaceutical and biotechnology companies.

Other attractive opportunities for pharmaceutical players include Singapore’s many innovation clusters, which unite researchers and manufacturers from the same industry, while customized medical technology hubs such as MedTech, Biopolis and Tuas biomedical park offer top-notch engineering capabilities.

Despite the relatively strong growth rate and apparent opportunities in the pharmaceuticals market, GlobalData believes there are several barriers that manufacturers should watch out for in the coming years. Government initiatives to promote the use of generics are being introduced to make drugs more readily available for patients by harmonizing the regulatory requirements, which may hinder the pharmaceutical market.

(Source: GlobalData)

Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!


Filed Under: Drug Discovery

 

Related Articles Read More >

Swissmedic approves first malaria treatment for infants
Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
Dupixent approved to treat bullous pemphigoid
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE